Applicability of the lung immune prognostic index (LIPI) in patients with metastatic solid tumors when treated with immune checkpoint inhibitors (ICI) in early clinical trials

被引：0
|
作者：
Varga, A. [1 ]
Bernard-Tessier, A. [2 ]
Auclin, E. [3 ]
Perez, L. Mezquita [2 ]
Baldini, C. [1 ]
Planchard, D. [2 ]
Marabelle, A. [1 ]
Hollebecque, A. [1 ]
Besse, B. [2 ]
Massard, C. [1 ]
机构：
[1] Gustave Roussy Canc Campus, Drug Dev Dept, Villejuif, France
[2] Gustave Roussy Canc Campus, Dept Canc Med, Villejuif, France
[3] Hop European George Pompidou, Oncol, Paris, France
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3O
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors
    Meyers, Daniel E.
    Stukalin, Igor
    Vallerand, Isabelle A.
    Lewinson, Ryan T.
    Suo, Aleksi
    Dean, Michelle
    North, Scott
    Pabani, Aliyah
    Cheng, Tina
    Heng, Daniel Y. C.
    Bebb, D. Gwyn
    Morris, Don G.
    CANCERS, 2019, 11 (11)
  • [2] Dynamic monitoring of lung immune prognostic index (LIPI) in thoracic tumours treated with immune checkpoint inhibitors
    Lopez Escola, Cristina
    Flores, Alvaro
    Robles, Marta
    Donnelly, Harry
    Hercules, Darlene
    Gomez, Kyle
    Roman, Juan
    Del Rio Valencia, Juan Carlos
    Moreno, Mamta
    Ballesteros, David
    LUNG CANCER, 2023, 178 : S46 - S46
  • [3] Association of the Lung Immune Prognostic Index (LIPI) with Outcomes for Immune Checkpoint Inhibitors in Diffuse SCLC Patients
    Mezquita, L.
    Aix, S. Ponce
    Auclin, E.
    Navarro, A.
    Planchard, D.
    Sullivan, I.
    Zalcman, G.
    Mazieres, J.
    Hendriks, L.
    Caramella, C.
    Majem, M.
    Lavaud, P.
    Nana, F. Aboubakar
    Felip, E.
    Paz-Ares, L.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S973 - S974
  • [4] Applicability of the lung immune prognostic index (LIPI) to metastatic triple negative breast cancer (mTNBC) patients treated with immune checkpoint targeted monoclonal antibodies (ICT mAbs)
    Vozy, A.
    Simonaggio, A.
    Auclin, E.
    Mezquita, L.
    Baldini, C.
    Martin-Romano, P.
    Pistilli, B.
    Gazzah, A.
    Bahleda, R.
    Ribrag, V.
    Postel-Vinay, S.
    Champiat, S.
    Soria, J-C.
    Andre, F.
    Massard, C.
    Besse, B.
    Delaloge, S.
    Varga, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 94 - 94
  • [5] Applicability of the LIPI score to metastatic microsatellite instability high cancer patients treated with immune checkpoint inhibitors
    Vuagnat, P.
    Auclin, E.
    Mezquita, L.
    Adeva Alfonso, J.
    Vidal Tocino, M. R.
    Longo Munoz, F.
    El Dakdouki, Y.
    Romano, P. Martin
    Baldini, C.
    Varga, A.
    Garcia-Carbonero, R.
    Besse, B.
    Massard, C.
    Hollebecque, A.
    ANNALS OF ONCOLOGY, 2019, 30 : 20 - 20
  • [6] Immune Prognostic Index as a predictor of survival in patients with metastatic melanoma treated with immune checkpoint inhibitors
    Stukalin, Igor
    Suo, Aleksi
    Vallerand, Isabelle A.
    Lewinson, Ryan
    Heng, Daniel Y. C.
    Bebb, D. Gwyn
    Morris, Don G.
    Cheng, Tina
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB100 - AB100
  • [7] The lung-immune prognostic index (LIPI) to predict early mortality among patients affected by advanced solid cancers under immune-checkpoint inhibitors treatments
    De Giglio, Andrea
    Filippini, Daria Maria
    Mollica, Veronica
    Rihawi, Karim
    Comito, Francesca
    Carosi, Francesca
    Marchetti, Andrea
    Ricciotti, Ilaria
    Gelsomino, Francesco
    Nobili, Elisabetta
    Melotti, Barbara
    Sperandi, Francesca
    Massari, Francesco
    Pantaleo, Maria A.
    Ardizzoni, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] The head and neck lung immune prognostic index (HN-LIPI): A prognostic score for immune checkpoint inhibitors (ICI) in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) patients
    Gomez, R. G. Herrera
    Mezquita, L.
    Auclin, E.
    Heraudet, L.
    Plana, M.
    Salas, S.
    Cristina, V.
    Garcia Castano, A.
    Arrazubi, V.
    Grau, J. J.
    Saleh, K.
    Cirauqui Cirauqui, B.
    Nin, R. Mesia
    Even, C.
    Taberna, M.
    Daste, A.
    Peters, S.
    Besse, B.
    Baste-Rotllan, N.
    ANNALS OF ONCOLOGY, 2019, 30
  • [9] Correlation of the Lung Immune Prognostic Index (LIPI) and PDL1 Status with Outcomes for Immune Checkpoint Inhibitors in Advanced NSCLC Patients
    Mezquita, L.
    Park, W.
    Arbour, K.
    Auclin, E.
    Hendriks, L.
    Planchard, D.
    Saravia, D.
    Ponce Aix, S.
    Nadal, E.
    Audigier-Valette, C.
    Carnio, S.
    Adam, J.
    Ruffinelli, J. C.
    Zalcman, G.
    Numico, G.
    Sullivan, I.
    Paz-Ares, L.
    Dingemans, A.
    Novello, S.
    Hellmann, M.
    Lopes, G.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S488 - S488
  • [10] Assessing the accuracy of multiple prognostic scores for immune checkpoint inhibitors (ICI) in patients with advanced solid tumors
    Garcia-Corbacho, J.
    Indacochea, A.
    Gonzalez, A.
    Victoria Ruiz, I.
    Moreno Fernandez, D.
    Pesantez Coronel, D. S.
    Angelats, L.
    Modrego, A.
    Sanfeliu Torres, E.
    Castillo, O.
    Blasco, P.
    Mezquita, L.
    Vinolas Segarra, N.
    Nogue Aliguer, M.
    Adamo, B.
    Baste Rotllan, N.
    Sauri Nadal, T.
    Juan, M.
    Prat, A.
    Schettini, F.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S594 - S595
12345